Development of a rapid, microplate-based kinetic assay for measuring adenosine deaminase activity in body fluids

Clinica Chimica Acta

Volumn 413, Issue 19-20, 2012, Pages 1637-1640

  Lu, Jun ^a   Grenache, David G ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine deaminase; Reference intervals; Tuberculosis; Tuberculous meningitis; Tuberculous peritonitis; Tuberculous pleuritis

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; INOSINE;

ANALYTIC METHOD; ANALYTICAL PARAMETERS; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENVIRONMENTAL TEMPERATURE; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME STABILITY; HUMAN; LIGHT ABSORPTION; LIMIT OF DETECTION; LINEAR SYSTEM; MICHAELIS CONSTANT; MICROPLATE BASED KINETIC ASSAY; MOLAR EXTINCTION COEFFICIENT; PERITONEAL FLUID; PLEURA FLUID; PRIORITY JOURNAL; REACTION TIME; REFERENCE VALUE; SENSITIVITY ANALYSIS; TUBERCULOUS MENINGITIS; TUBERCULOUS PERITONITIS; TUBERCULOUS PLEURISY; VALIDATION PROCESS;

ADENOSINE; ADENOSINE DEAMINASE; ASCITIC FLUID; BIOLOGICAL ASSAY; BODY FLUIDS; CEREBROSPINAL FLUID; ENZYME STABILITY; HUMANS; INOSINE; KINETICS; PLEURAL EFFUSION; REFERENCE STANDARDS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84864382345     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.05.001     Document Type: Article

References (16)

1. Fischer A. Severe combined immunodeficiencies (SCID). Clin Exp Immunol Nov. 1 2000, 122(2):143-149.
2. Porcel J.M., Esquerda A., Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med Oct. 2010, 21(5):419-423.
3. Sanai F.M., Bzeizi K.I. Systematic review: tuberculous peritonitis-presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther Oct. 15 2005, 22(8):685-700.
4. Xu H.-B., Jiang R.-H., Li L., Sha W., Xiao H.-P. Diagnostic value of adenosine deaminase in cerebrospinal fluid for tuberculous meningitis: a meta-analysis. Int J Tuberc Lung Dis Nov. 2010, 14(11):1382-1387.
5. Giusti G., Galanti B. Adenosine deaminase: colorimetric method. Methods of enzymatic analysis 1984, vol. 4:315-323. Verlag Chemie. 3rd ed. H.U. Bergmeyer (Ed.).
6. Kaplan N.O. Specific adenosine deaminase from intestine. Methods Enzymol 1955, 2:473-475.
7. Ellis G., Goldberg D.M. A reduced nicotinamide adenine dinucleotide-linked kinetic assay for adenosine deaminase activity. J Clin Lab Med 1970, 76:507-517.
8. Hopkinson D.A., Cook P.J.L., Harris H. Further data on the adenosine deaminase (ADA) polymorphism and a report of a new phenotype. Ann Hum Genet 1969, 32:361-367.
9. Oosthuizen H.M., Ungerer J.P., Bissbort S.H. Kinetic determination of serum adenosine deaminase. Clin Chem Oct. 1 1993, 39(10):2182-2185.
10. Kaplan N.O., Colowick S.P., Ciotti M.M. Enzymatic deamination of adenosine derivatives. J Biol Chem Feb. 1952, 194(2):579-591.
11. National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of Tuberculosis Elimination. Reported tuberculosis in the United States, 2010 2010, 134. CDC. R. Miramontes (Ed.).
12. WHO WHO global tuberculosis control report 2010. Cent Eur J Public Health Dec. 2010, 237.
13. Kataria Y.P., Khurshid I. Adenosine deaminase in the diagnosis of tuberculous pleural effusion. Chest Aug. 2001, 120(2):334-336.
14. Phypers M., Harris T., Power C. CNS tuberculosis: a longitudinal analysis of epidemiological and clinical features. Int J Tuberc Lung Dis Jan. 2006, 10(1):99-103.
15. Giusti G., Gakis C. Temperature conversion factors, activation energy, relative substrate specificity and optimum pH of adenosine deaminase from human serum and tissues. Enzyme 1971, 12(4):417-425.
16. Delacour H., Sauvanet C., Burnat P. Analytical performances of the Diazyme ADA assay on the Cobas(®) 6000 system. Clin Biochem 2010, 43(18):1468-1471.